Subjects: LEISHMANIOSE VISCERAL, PROTEÍNAS RECOMBINANTES, DIAGNÓSTICO
ABNT
FUJIMORI, Mahyumi et al. Recombinant protein KR95 as an alternative for serological diagnosis of human visceral leishmaniasis in the Americas. PLOS ONE, v. 18, n. 3, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54009. Acesso em: 11 dez. 2024.APA
Fujimori, M., Valencia-Portillo, R. T., Lindoso, J. A. L., Celeste, B. J., Almeida, R. P. de, Costa, C. H. N., et al. (2023). Recombinant protein KR95 as an alternative for serological diagnosis of human visceral leishmaniasis in the Americas. PLOS ONE, 18( 3). doi:10.1371/journal.pone.0282483NLM
Fujimori M, Valencia-Portillo RT, Lindoso JAL, Celeste BJ, Almeida RP de, Costa CHN, Cruz AM da, Druzian AF, Duthie MS, Fortaleza CMCB, Oliveira ALL de, Paniago AMM, Queiroz IT, Reed S, Vallur AC, Goto H, Sanchez MCA. Recombinant protein KR95 as an alternative for serological diagnosis of human visceral leishmaniasis in the Americas [Internet]. PLOS ONE. 2023 ; 18( 3):[citado 2024 dez. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54009Vancouver
Fujimori M, Valencia-Portillo RT, Lindoso JAL, Celeste BJ, Almeida RP de, Costa CHN, Cruz AM da, Druzian AF, Duthie MS, Fortaleza CMCB, Oliveira ALL de, Paniago AMM, Queiroz IT, Reed S, Vallur AC, Goto H, Sanchez MCA. Recombinant protein KR95 as an alternative for serological diagnosis of human visceral leishmaniasis in the Americas [Internet]. PLOS ONE. 2023 ; 18( 3):[citado 2024 dez. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54009